The Advisory Board at AXIM Biotech is composed of highly qualified individuals considered leaders in their respective fields of expertize both nationally and internationally. Our Advisers’ responsibilities include helping in the research and development of novel and groundbreaking pharmaceutical and nutraceutical preparations, alternative energy sources and formulations, strategic financial planning as well as mergers and acquisitions.
Prof. Renger Witkamp
Prof. John Zajicek
Dr. Arno Hazekamp
Warren C. Hutchins
Dr. Murad A. Sunalp
Dr. Jacques F. Meis
Dr. Ilya Reznik
Dr. Robert Ritch
Dr. Emil Engels
Professor Renger Witkamp
Professor Renger Witkamp studied Biology and Pharmacy at the Utrecht University (NL). He obtained his pharmacist degree in 1987 and started his career as pharmacist/lecturer at the Veterinary Faculty of the Utrecht University, which was combined with his Ph.D. training on experimental pharmacokinetics. After his Ph.D., he continued as an assistant professor, and later as an associate professor at the Utrecht University, until 1996. Subsequently, he moved to TNO, the Netherlands’ Organization for Applied Research.
At TNO, he held several scientific and managerial positions. In 2006, he became a professor in Nutrition and Pharmacology at Wageningen University, which at that time was a newly established academic chair. His group focuses on teaching and researching concepts and applications of the interface between food and pharma, including medical nutrition and drug-nutrient combinations. Research is predominantly directed at further elucidating the actions of plant cannabinoids and endocannabinoids on inflammatory processes and eating behavior. Practical applications of this program include muscle preservation during chronic disease and intestinal disorders.
Professor John Zajicek
Professor John Zajicek Chair in Medicine at the University of St. Andrews School of Medicine, Institute of Behavioural and Neural Sciences. Professor Zajieck trained in Medicine at Cambridge and St Mary’s Hospital in London. He completed a Ph.D. in cell biology of myelination in Cambridge. He then moved to Plymouth in 1995 as a neurologist where he was involved in both laboratory and clinical research. He is Chair of Clinical Neuroscience at Plymouth University, Director of the Peninsula Clinical Trials Unit, and Chair of the UK NIHR Nervous System Disorders Specialty Group. Zajicek has served on the UK MRC Neuroscience and Mental Health Board and the MRC Methodology Panel. He is particularly interested in the way Axim Biotechnologies develops trials for neurodegenerative diseases. He has been Chief Investigator in several large multicentre randomized controlled trials, including the investigation of cannabinoid use in multiple sclerosis. Professor Zajicek has authored many papers on cannabinoids, multiple sclerosis and the methodology of clinical trials in neurodegeneration.
Dr. Arno Hazekamp
Dr. Arno Hazekamp studied at Leiden University in the Netherlands, where he obtained his Bachelor’s degree in the field of Molecular Biology, followed by an MSc in Biopharmaceutical Sciences. After finishing his research on Thai traditional medicine, he graduated with honors in 2000.
Subsequently, Arno started his Ph.D., focused on the medicinal properties of the cannabis plant, and on the practical obstacles that stand between this plant and its development into a modern medicine. Arno was able to work closely with the official grower of medicinal cannabis in the Netherlands, Bedrocan BV, and was involved in numerous projects regarding the chemical analysis, quality control, and product development regarding medicinal cannabis. He was actively involved in setting up the medicinal cannabis program of the Dutch Health Ministry and became a strong advocate of a more science-based approach to the medicinal use of cannabis in the Netherlands and abroad.
After finishing his Ph.D., Arno continued to set up his own consultancy lab for analysis of medicinal plants while keeping a special interest in cannabis. As an independent researcher, Arno worked closely with government agencies, universities, and pharmaceutical companies. Some relevant experiences during this period (2005-2011) include his involvement in the early phase of Echo Pharmaceuticals (a Dutch pharmaceutical company developing a sublingual administration form of THC and other cannabinoids) and validation studies for the German company Storz & Bickel (e.g., the basis for the successful development of the Volcano Medic, a vaporizer device specifically designed for inhalation of medicinal cannabis).
Arno is considered an expert on standardized growing, quality control, and product development. He is an active traveler and medicinal cannabis advocate. In 2011, Arno became the head of Research and Development (R&D) of Bedrocan BV, where he currently works on the preparation of clinical trials with medicinal cannabis.
Warren C. Hutchins
Warren Hutchins is an energetic leader with a career that has spanned the globe. He is a skilled financial deal-maker with the ability to build successful teams and work in multicultural environments. Creating global strategic alliances throughout his business life, Hutchins has excelled at identifying key relationships and channels leading to profitable agreements with significant financial partners in Asia-Pacific, Europe, the Middle East, South America and North America. His business experience encompasses extensive involvement in commercial, investment and private banking and bank management.
Hutchins’ success across the continents is not limited to the financial sector. He has demonstrated a consistent dedication and commitment to not-for-profit organizations, lending his intellectual capital and keen leadership skills to develop long-term strategic plans and increase awareness. Hutchins has served on a variety of charitable, cultural/musical and educational boards as both Director and President, from the University of the Andes foundation to a U.S. affiliate of the Royal College of Music in London to the Russian Nobility Association in America. His civic leadership also displays a breadth of experience with diverse international cultures. He has been recognized by both Russian Nobility and British Royalty for his exhaustive efforts on each entity’s behalf, including his appointment as Honorary Member of The Royal College of Music by the late Queen Mother. A natural linguist, he welcomes business and philanthropic challenges in all corners of the world.
Dr. Murad A. Sunalp
Murad Sunalp is well respected nationally and internationally as an ophthalmologist, entrepreneur and contributor to charitable vision surgeries worldwide. Dr. Sunalp trained at the most prestigious institutions including Oxford and Stanford. He brings with him a clinical and academic wealth of knowledge spanning over 30 years.
Dr. Sunalp offers extensive expertise on diseases of the eye and has performed more than 20,000 cataract surgeries and over 5,000 LASIK procedures in his clinical practice. His specialties include anterior segment, intraocular lens and phacoemulsification cataract surgery; LASIK and Excimer refractive surgery; and VISX CustomVue individualized laser vision correction as well as glaucoma, PRK and CK procedures.
Throughout his 37-year career, Dr. Sunalp has been involved in more than 65 ophthalmologic publications and studies along with numerous charitable surgeries in four countries.
Dr. Jacques F. Meis
Dr. Jacques F. Meis is a consultant microbiologist at Canisius-Wilhelmina Hospital in Nijmegen, The Netherlands, a large teaching hospital; and an honorary consultant at the Radboud University Medical Center in the same city. In addition to an MD, he holds a Ph.D. in Science, is a board-certified medical specialist in the Netherlands and is a Fellow of the Infectious Diseases Society of America and the Royal College of Pathology in the UK.
He is a former President of the Dutch Society for Medical Mycology, former President of the European Confederation for Medical Mycology, and former Chairman of the External Quality Control Program in Bacteriology and Mycology in the Netherlands.
In addition to being Senior Editor of Mycoses, he is a voting member on the CLSI Subcommittee on Antifungal Susceptibility Testing. He is (co)author of more than 350 peer-reviewed PubMed-included publications. His current research focuses on diagnosis, treatment, molecular typing and antifungal susceptibility of the opportunistic fungi Aspergillus, Cryptococcus and Candida in addition to other rare filamentous fungi.
Marvin Washington works for William Small Wealth Management Group as a Financial Advisor; primarily serving individuals with a select number of Professional Athletes in the NFL and NBA. He has 10 years of experience working in the financial Services field – more specifically in financial planning, retirement planning and estate planning.
He is a retired NFL player who played a total of eleven years with three teams: the New York Jets, Denver Broncos and San Francisco 49ers. He was a member of the Denver Broncos 1998 Super Bowl winning team and was voted by Sports Illustrated as the 36th best N.Y. Jet of all-time. He is a graduate of Idaho University where he is also a 2004 inductee into the University of Idaho Vandal Sports Hall of Fame. He is a Dallas native who is involved with several charities and sits on the Board of Texas Can Charter School. He has three children, two sons; Evan 22, Isaiah 16 and a daughter; Sydney 20. His oldest, Evan Washington is following in his football footsteps playing at L.S.U.
For over 20 years, Joe Grace has successfully grown health and wellness startups with highly efficient direct marketing strategies. As the Head of Online Marketing at WebMD, Joe is credited with growing this innovative health portal into the most trusted and successful source for online health information with over 25 million unique monthly visitors. His responsibilities also included working with sponsors (top pharma and medical device brands) to create ground breaking DTC marketing campaigns to reach health interested consumers across over 20 therapeutic conditions. His health and wellness marketing experience includes prescription drugs, medical devices, OTC drugs, skincare, weight loss and more. As the Head of Marketing at Medscape, Joe was responsible for growing this struggling physician portal into one of the top rated destination for physician education. Joe has also worked extensively with Private Equity and Venture Capital firms on broad range of health and wellness transactions. .
Joe holds a BS in Electrical Engineering and Computer Science from Cornell University. He also holds an MBA from the Johnson School of Management at Cornell University.
Dr. Ilya Reznik
Dr. Ilya Reznik is a Board-certified specialist in Adult Forensic & Clinical NeuroPsychiatry at MaReNa Diagnostic and Consulting Center, Israel. Dr. Reznik has superior educational and professional record and documented contributions to the field of neuropsychiatric research, such as publications and other innovative activities. Dr. Reznik has published many original papers (including controlled trials), reviews and case reports in leading peer-reviewed journals in the field of clinical psychiatry and neuropsychopharmacology. His current main interest is in the field of the medical use of cannabis and cannabinoids, especially for various neuropsychiatric illnesses, such as Chronic Pain Syndrome, Fibromyalgia, Post-Traumatic Stress Disorder (PTSD), OCD, Gilles de la Tourette syndrome, Parkinson’s and Alzheimer diseases etc. During last 7 years, he coordinated the activity of Israel National Forum/Association for Medical Cannabis Research & Treatment. He is Associate Member of The Canadian Consortium for the Investigation of Cannabinoids (CCIC), Member of International Cannabinoid Research Society (ICRS). In 2013 he was elected to the Board of Directors, International Association for Cannabinoid Medicines (IACM) and promotes educational and international activity within IACM.
Dr. Robert Ritch
Dr. Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director Emeritus and Chief of Glaucoma Services at the New York Eye & Ear Infirmary of Mount Sinai, New York City and Professor of Ophthalmology at The New York Medical College, Valhalla, New York. He has devoted his career to broadening our understanding of the underlying etiologies and mechanisms of glaucoma and innovation in its medical, laser, and surgical treatment. Dr. Ritch received his B.A. cum laude from Harvard College and an M.A. in cell biology from Harvard University. He received his M.D. from Albert Einstein College of Medicine and, after an internship at St. Vincent’s Medical Center and a residency in Ophthalmology at Mount Sinai School of Medicine, received fellowships in glaucoma from the Heed Foundation and the National Institutes of Health. A Diplomate of the American Board of Ophthalmology, he is a Fellow of the American Academy of Ophthalmology, the American College of Surgeons, the International College of Surgeons, the Royal College of Ophthalmology, the Association for Research in Vision and Ophthalmology, and the New York Academy of Medicine, and is a member of more than 35 scientific and medical societies.
Dr. Emil Engels
Dr. Emil Engels, MD, MBA, CPC, is a nationally renowned anesthesiologist and healthcare consultant. He received his medical degree from Yale University and did his residency at Harvard Medical School (Brigham and Women’s Hospital). He completed a fellowship in cardiac anesthesia, also at Harvard. In addition, he earned an executive MBA from the University of Tennessee.
Dr. Engels practices as an anesthesiologist at INOVA Fairfax Hospital, where he is a partner with Fairfax Anesthesiology Associates/American Anesthesiology of Virginia. He lectures nationally on healthcare reform and publishes frequent articles in anesthesia literature.
Dr. Engels has held numerous leadership positions, both within his practice and in external organizations. He is the current President of the Virginia Society of Anesthesiologists and a member of the Board of Directors for the American Society of Anesthesiologists. He also sits on the Medicare Carrier Advisory Committee for Novitas Solutions.
In addition to his clinical expertise, Dr. Engels is well regarded for his skills in healthcare billing, advocacy, and regulatory compliance. He is actively engaged in fighting the opioid abuse problem and has served on both state and national panels to address it. Dr. Engels brings to AXIM a wealth of clinical experience, along with an understanding of the complex changes occurring in the U.S. healthcare system.